ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host a ...
Insulet covered its 58,000 square-foot manufacturing facility with approximately 2,800 solar panels, each measuring 5.5 feet long by 3.3 feet wide. During optimal climate conditions, the solar energy ...
BILLERICA, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today ...
Insulet () has held its Q1 earnings call. Read on for the main highlights of the call. Meet Samuel – Your Personal Investing Prophet. Start a conversation with TipRanks’ trust ...
Acton medical device company Insulet will begin powering its corporate headquarters and manufacturing facility with solar energy, the company announced on Wednesday. Beginning in January, the company ...
In recent weeks, Insulet has expanded a voluntary Medical Device Correction and faced an FDA Class I recall of certain Omnipod 5 insulin pump pods after identifying a defect that could cause insulin ...
“We are taking an important step to further diversify globally and ensure our valued customers continue to have uninterrupted access to our life-changing products,” said Chuck Alpuche, Insulet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results